Balaji Amines Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹468 Cr +37.2% YoYSee revenue, profit and what management said. You are viewing Q3 FY24.
BA

Balaji Amines Ltd

Q3 FY24Chemicals & Petrochemicals

Balaji Amines Q3 FY24: Revenue ₹392 Cr, PAT ₹56 Cr

Q3 FY24 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹383Cr
+0.5% QoQ
Net profit
₹56Cr
+55.6% QoQ
Margin
19%
+5 pp QoQ

Based on Balaji Amines Ltd's Q3 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹2,226
Market cap₹7.0K Cr
P/E34.5

The short version

Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7). Q3FY24 Consolidated EBITDA: ₹83 crore (up from ₹61 crore in Q2FY24) - Q3FY24 Consolidated EBITDA Margin: 21% (up from 16% in Q2FY24; down YoY from 22% in Q3FY23) - Q3FY24 Consolidated PAT: ₹56 cro

From Balaji Amines Ltd's Q3 FY24 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7).
  • Q3FY24 segmented volumes: Amines 7,703 MT, Amines Derivatives 9,280 MT, Specialty Chemicals 9,920 MT (Page 7).
  • Q3FY24 standalone revenue: ₹314 crore, down 24% YoY from ₹416 crore in Q3FY23 (Page 5).
  • 9MFY24 consolidated revenue: ₹1,248 crore, down 34% YoY from ₹1,894 crore in 9MFY23 (Page 6).

2 more points from Balaji Amines Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Balaji Amines Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Unit 4 Greenfield Project (90-acre in MIDC Chincholi, Solapur):
  • Phase 1 completed: Ethylamines plant (operational May 2021), DMC/PC and PG plants (operational Sep 2022).
  • Phase 2 & 3 Capex: Rs. 300-350 crore over FY24 and FY25, mostly internal accruals.
  • Phase 2 Expansion:
  • N-Butylamine plant (15,000 TPA), targeted commissioning Q4 FY24.
  • Methylamine plant (40,000 TPA capacity), commissioning Q2 FY25; company is market leader with 48,000 TPA installed capacity.
  • Phase 3 Expansion:
  • Dimethyl Ether (DME) plant (100,000 TPA), commissioning H1 FY25.
  • Proposed additions: N-Methylmorpholine, Pharmapure Povidone, NBPT.
  • Other details:

2 more points from Balaji Amines Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Balaji Amines Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

- No reference to order book size or value.

Balaji Amines Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Balaji Amines Ltd Q3 FY24 results — key figures

Balaji Amines Ltd Q3 FY24 reported results vs year-ago quarter, ₹ crore
₹ CrQ3 FY24Q2 FY24QoQ
Revenue383381+0.5%
Operating profit (EBITDA)7454+37%
Operating margin19%14%+5 pp
Profit before tax7048+45.8%
Net profit (PAT)5636+55.6%
EPS (₹)15.2410.71+42.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹468 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q3 FY24)

    1,052.51 Cr, up 1.46% YoY from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.

  • Gujarat Alkalies (Q3 FY24)

    3,702.77 crores, down from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.

  • Vidhi Specialty (Q3 FY24)

    Year-on-Year (Y-o-Y) change: -27.1% (Q3 FY24 vs Q3 FY23) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY24 earnings call — and how it…

  • Chemcon Speciality Chemicals (Q3 FY24)

    53.0 Cr, down 30.7% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Balaji Amines Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Balaji Amines Ltd Q3 FY24 results?

Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7). Q3FY24 Consolidated EBITDA: ₹83 crore (up from ₹61 crore in Q2FY24) - Q3FY24 Consolidated EBITDA Margin: 21% (up from 16% in Q2FY24; down YoY from 22% in Q3FY23) - Q3FY24 Consolidated PAT: ₹56 cro

What is Balaji Amines Ltd share price analysis?

Balaji Amines Ltd currently shows a neutral. The stock trades at a P/E of 34.5 with a market cap of ₹7,036 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Balaji Amines Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.